Analyze Diet
Transboundary and emerging diseases2008; 55(9-10); 411-416; doi: 10.1111/j.1865-1682.2008.01051.x

Public health use of surveillance for West Nile virus in horses: Saskatchewan, 2003-2005.

Abstract: West Nile virus (WNV) infection in horses was first reported in Canada in 2001 and in the province of Saskatchewan in 2002. This paper outlines the surveillance results of WNV in Saskatchewan horses from 2003 to 2005 and describes the usefulness of its inclusion in an integrated surveillance program in Saskatchewan. The number of human and horse cases was highest in 2003, the epidemic year and then substantially lower in 2004 and 2005. Horses provided additive information about WNV activity in rural areas with low human population, however, this required willingness and active participation by veterinarians and horse owners. Vaccination impedes the future use of horses in WNV surveillance for public health or veterinary purposes; however, for zoonoses where no vaccination is available, domestic animals would be useful components for surveillance. Integration of surveillance data from human and animal health provide the benefit of a more complex epidemiological picture that can be used to improve public health.
Publication Date: 2008-08-27 PubMed ID: 18761655DOI: 10.1111/j.1865-1682.2008.01051.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on the monitoring and surveillance results of West Nile virus (WNV) in horses in Saskatchewan, Canada from 2003 to 2005. It also emphasizes the importance of integrating human and animal health data to create a broader epidemiological picture for public health improvement.

Background

  • West Nile virus (WNV) is a disease that first appeared in Canada in 2001 and in the province of Saskatchewan in 2002. The virus infects humans and animals, and this study focuses on the infection rates in horses.
  • The research tracks the cases of the virus over a period from 2003 to 2005, with particular attention given to its peaks and troughs. This information helps to create a clearer picture of how the disease spreads and behaves over time.

Results

  • The study revealed that the number of cases in both humans and horses was at its highest in 2003, which was identified as the epidemic year. Cases were significantly lower in 2004 and 2005.
  • While it was observed that the use of horses in monitoring West Nile virus gave valuable additional information about the spread of WNV in rural areas with low human population, this took the active participation and agreement of veterinarians and horse owners.

Implications and Recommendations

  • The research indicates that vaccination is an obstacle in using horses for future WNV surveillance for public health or veterinary purposes. Vaccinations interfere with the ability to track and monitor the disease effectively.
  • The study suggests that for zoonotic diseases (diseases transmitted from animals to humans) where there’s no vaccine available, domestic animals could play a key role in disease surveillance.
  • The paper highlights the value of integrating surveillance data from both human and animal health sectors. By doing so, a comprehensive epidemiological picture is obtained, which, in turn, enhances the ability to improve public health.

Cite This Article

APA
Epp T, Waldner C, Corrigan R, Curry P. (2008). Public health use of surveillance for West Nile virus in horses: Saskatchewan, 2003-2005. Transbound Emerg Dis, 55(9-10), 411-416. https://doi.org/10.1111/j.1865-1682.2008.01051.x

Publication

ISSN: 1865-1674
NlmUniqueID: 101319538
Country: Germany
Language: English
Volume: 55
Issue: 9-10
Pages: 411-416

Researcher Affiliations

Epp, T
  • Department of Large Animal Clinical Sciences, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, SK, Canada. tasha.epp@usask.ca
Waldner, C
    Corrigan, R
      Curry, P

        MeSH Terms

        • Animals
        • Female
        • Horse Diseases / epidemiology
        • Horse Diseases / transmission
        • Horses
        • Humans
        • Male
        • Public Health
        • Saskatchewan / epidemiology
        • Sentinel Surveillance / veterinary
        • West Nile Fever / epidemiology
        • West Nile Fever / transmission
        • West Nile Fever / veterinary
        • Zoonoses

        Citations

        This article has been cited 5 times.
        1. Levasseur A, Arsenault J, Paré J. Surveillance of West Nile virus in horses in Canada: A retrospective study of cases reported to the Canadian Food Inspection Agency from 2003 to 2019. Can Vet J 2021 May;62(5):469-476.
          pubmed: 33967285
        2. Kulkarni MA, Berrang-Ford L, Buck PA, Drebot MA, Lindsay LR, Ogden NH. Major emerging vector-borne zoonotic diseases of public health importance in Canada. Emerg Microbes Infect 2015 Jun 10;4(6):e33.
          doi: 10.1038/emi.2015.33pubmed: 26954882google scholar: lookup
        3. Hubálek Z, Ludvíková E, Jahn P, Treml F, Rudolf I, Svobodová P, Šikutová S, Betášová L, Bíreš J, Mojžíš M, Tinák M, Boldižár M, Citsoňová G, Staššíková Z. West Nile Virus equine serosurvey in the Czech and Slovak republics. Vector Borne Zoonotic Dis 2013 Oct;13(10):733-8.
          doi: 10.1089/vbz.2012.1159pubmed: 23919605google scholar: lookup
        4. Epp TY, Waldner C, Berke O. Predictive risk mapping of West Nile virus (WNV) infection in Saskatchewan horses. Can J Vet Res 2011 Jul;75(3):161-70.
          pubmed: 22210991
        5. Levasseur A, Paré J, Aubry P, Iwasawa S, Leung D, Arsenault J. Stochastic modeling of the horse population and vaccination data indicates low annual vaccination coverage for West Nile virus in Canada (2016-2020). Can J Vet Res 2025 Apr;89(2):54-63.
          pubmed: 40170915